{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Molecular docking", "Thiazole", "Triazine", "\u03b1-Glucosidase"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29587132", "DateCompleted": {"Year": "2019", "Month": "01", "Day": "28"}, "DateRevised": {"Year": "2019", "Month": "01", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "03", "Day": "21"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bioorg.2018.03.015", "S0045-2068(18)30035-X"], "Journal": {"ISSN": "1090-2120", "JournalIssue": {"Volume": "78", "PubDate": {"Year": "2018", "Month": "Aug"}}, "Title": "Bioorganic chemistry", "ISOAbbreviation": "Bioorg Chem"}, "ArticleTitle": "Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of \u03b1-glucosidase inhibitors.", "Pagination": {"StartPage": "195", "EndPage": "200", "MedlinePgn": "195-200"}, "Abstract": {"AbstractText": ["A novel 5,6-diaryl-1,2,4-triazine thiazole derivatives (7a-7q) were synthesized and characterized by <sup>1</sup>H NMR and <sup>13</sup>C NMR and evaluated for their \u03b1-glucosidase inhibitory activity. All tested compounds displayed good \u03b1-glucosidase inhibitory activity with IC<sub>50</sub> values ranging between 2.85\u202f\u00b1\u202f0.13 and 14.19\u202f\u00b1\u202f0.23\u202f\u03bcM when compared to the standard drug acarbose (IC<sub>50</sub>\u202f=\u202f817.38\u202f\u00b1\u202f6.27\u202f\u03bcM). Compound 7i (IC<sub>50</sub>\u202f=\u202f2.85\u202f\u00b1\u202f0.13\u202f\u03bcM) exhibited the highest activity among this series of compounds. Molecular docking studies were carried out in order to investigate the binding mode of this class of compounds to \u03b1-glucosidase. This study showed that these 5,6-diaryl-1,2,4-triazine thiazole derivatives are a new class of \u03b1-glucosidase inhibitors."], "CopyrightInformation": "Copyright \u00a9 2018 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pharmaceutics, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550004, China; Guizhou Provincial Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Guizhou Medical University, Guiyang 550004, China; School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Wang", "ForeName": "Guangcheng", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pharmaceutics, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550004, China; Guizhou Provincial Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Guizhou Medical University, Guiyang 550004, China; School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Peng", "ForeName": "Zhiyun", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pharmaceutics, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550004, China; School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Gong", "ForeName": "Zipeng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Guizhou Medical University, Guiyang 550004, China; School of Pharmacy, Guizhou Medical University, Guiyang 550004, China. Electronic address: liyongjun_gmu@163.com."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Bioorg Chem", "NlmUniqueID": "1303703", "ISSNLinking": "0045-2068"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Glycoside Hydrolase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Thiazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Triazines"}, {"RegistryNumber": "290-38-0", "NameOfSubstance": "1,2,4-triazine"}, {"RegistryNumber": "EC 3.2.1.20", "NameOfSubstance": "alpha-Glucosidases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Glycoside Hydrolase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Thiazoles"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Triazines"}, {"QualifierName": ["metabolism"], "DescriptorName": "alpha-Glucosidases"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "1", "Day": "14"}, {"Year": "2018", "Month": "3", "Day": "8"}, {"Year": "2018", "Month": "3", "Day": "18"}, {"Year": "2018", "Month": "3", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "28", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29587132", "10.1016/j.bioorg.2018.03.015", "S0045-2068(18)30035-X"]}}]}